B-CELL LYMPHOMA REFRACTORY
Clinical trials for B-CELL LYMPHOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA REFRACTORY trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat lymphoma in the brain: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug, selinexor, combined with standard chemotherapy for people with B-cell lymphoma that has returned or not responded to treatment and has spread to the brain or spinal cord. The goal is to see if the combination is safe and effective. About 37 adults wil…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 01, 2026 15:43 UTC
-
New CAR T-Cell therapy offers hope for Hard-to-Treat lymphoma patients
Disease control Recruiting nowThis study tests a personalized CAR T-cell therapy for people with B-cell lymphoma that has come back or not responded to other treatments. About 30 participants will receive immune cells engineered to target their cancer. The goal is to find the safest and most effective dose an…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC